Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Civista Bancshares to Release Q4 2025 Financial Results

Civista Bancshares, Inc. has announced that it will release its fourth quarter 2025 financial results before the market opens on Thursday, January 29, 2026. The company will also host a conference call and webcast at 1:00 p.m. Eastern Time on the same day to discuss these results. Analysts will have the opportunity to participate in the question-and-answer session.

Civista Bancshares, Inc. is a $4.4 billion financial holding company headquartered in Sandusky, Ohio. Its primary subsidiary, Civista Bank, offers full-service banking, commercial lending, mortgage, and wealth management services. The bank currently operates 44 locations across Ohio, southeastern Indiana, and northern Kentucky. Additionally, Civista Bank provides commercial equipment leasing services nationwide through its Civista Leasing and Finance division, based in Pittsburgh, Pennsylvania.

As of the latest announcement, Civista Bancshares' common shares are traded on the NASDAQ Capital Market under the symbol "CIVB."

Today the company's shares have moved -1.45% to a price of $23.79. For the full picture, make sure to review CIVISTA BANCSHARES, INC.'s 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS